Progressive hyperleukocytosis during initial therapy is a predictive marker for differentiation syndrome and early mortality in adult patients with acute promyelocytic leukemia

Category Primary study
JournalBlood
Year 2016
This article has no abstract
Epistemonikos ID: a2100116b2bc214529019ead4fa7682d86b10329
First added on: Feb 08, 2025